Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161211 · ClinicalTrials.gov registry record · NA
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02161211 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 300 participants.
The verdict
NCT02161211, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.
Interventions
- BEHAVIORAL Combined
- BEHAVIORAL De-coupling
- BEHAVIORAL Anxiety Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-07 |
| Est. Completion | 2020-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02161211
The ClinicalTrials.gov registry entry for NCT02161211 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Combined is the first listed.
NCT02161211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02161211 about?
NCT02161211 is a clinical study titled "Dismantling the Components and Dosing of CBT for Co-Occurring Disorders". The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.
What is the current status of trial NCT02161211?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2014-07. Estimated completion is 2020-06-19.
What interventions are being tested in trial NCT02161211?
The interventions under investigation include: Combined (BEHAVIORAL), De-coupling (BEHAVIORAL), Anxiety Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02161211?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.